SHANGHAI – Moderna will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest pharmaceutical market even as geopolitical tensions rise.
The Chinese financial hub is home to the mainland headquarters of several global pharmaceutical companies along with local biotech firms. Moderna will work with the local government to conduct clinical trials and apply to bring products to the market as well as to produce and sell them in China. Any medicines produced under the deal will be only for the Chinese market, targeting unmet needs for patients in the country and won’t be exported, Moderna said.
China, meanwhile, hasn’t approved any western Covid-19 vaccines, inoculating its 1.4 billion population largely with less potent inactivated shots developed by local companies.
Canada Canada Latest News, Canada Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »